Muscle wasting assessment tools for prostate cancer

Sci Rep. 2022 Mar 18;12(1):4662. doi: 10.1038/s41598-022-08501-9.

Abstract

Prostate cancer and its treatment may induce muscle wasting. Body composition and muscle functionality are rarely assessed in patients with prostate cancer from developing countries due to the limited availability of high-quality equipment for routine diagnosis. This cross-sectional study evaluated the association between several simplistic techniques for assessing muscle mass and function with a more complex standard of reference for muscle wasting among Mexican men with prostate cancer. Muscle wasting was highly prevalent, yet it was presumably associated with aging rather than cancer and its treatment itself. The restricted availability of specific equipment in clinical settings with technological limitations supports using unsophisticated techniques as surrogate measurements for muscle wasting. The left-arm handgrip dynamometry displayed the highest correlation with the standard of reference and exhibited an acceptable predicted probability for muscle estimation. Combining several simplistic techniques may be preferable. We also developed and internally validated a manageable model that helps to identify elderly patients with prostate cancer at risk of muscle depletion and impairment. These findings promote the early recognition and treatment of muscle wasting alterations occurring among older adults with prostate cancer.

MeSH terms

  • Aged
  • Cross-Sectional Studies
  • Hand Strength* / physiology
  • Humans
  • Male
  • Muscle, Skeletal
  • Muscles
  • Muscular Atrophy
  • Prostatic Neoplasms* / complications